PROBLEM TO BE SOLVED: To provide novel administration means of tofacitinib or a pharmaceutically acceptable salt thereof, the means being capable of exhibiting an excellent medicinal effect while avoiding side effects that may be caused associated with an oral administration, in the prevention or treatment of rheumatoid arthritis.SOLUTION: The invention relates to a percutaneous absorption type preparation having a support and a drug-containing layer, the drug-containing layer containing tofacitinib or a pharmaceutically acceptable salt thereof, an adhesive and an absorption promoter, and the adhesive agent containing at least one kind selected from the group consisting of acrylic resin and rubber resin as main components.SELECTED DRAWING: NoneCOPYRIGHT: (C)2017,JPO&INPIT【課題】関節リウマチの予防または治療において、経口投与に伴って生じうる副作用を回避しつつ、優れた薬理効果を発揮させることが可能な、トファシチニブまたはその薬学的に許容される塩の新規投与手段を提供する。【解決手段】支持体と薬物含有層とを有する経皮吸収型製剤であって、該薬物含有層が、トファシチニブまたはその薬学的に許容される塩、粘着剤および吸収促進剤を含有し、該粘着剤がアクリル系樹脂およびゴム系樹脂からなる群より選ばれる少なくとも1種を主成分として含有する、経皮吸収型製剤。【選択図】なし
